Drugmakers should not be allowed to substitute electronic labels for paper documents because doing so could compromise public health, the Government Accountability Office found. Although e-labeling could allow faster drug updates for patients, pharmacists and health care providers, 14 million people have inadequate access to the Internet and some websites where e-labels are posted are difficult to navigate, the GAO said. "Stakeholders we spoke with suggested that having drug labeling available in both paper and electronic form would best serve patients because it would allow them to take advantage of both options," said Marcia Crosse, director of health care at the GAO.

Related Summaries